vs

Side-by-side financial comparison of Inogen Inc (INGN) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $46.6M, roughly 1.5× SolarMax Technology, Inc.). On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs 3.4%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.

INGN vs SMXT — Head-to-Head

Bigger by revenue
INGN
INGN
1.5× larger
INGN
$68.6M
$46.6M
SMXT
Growing faster (revenue YoY)
SMXT
SMXT
+620.1% gap
SMXT
623.5%
3.4%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
SMXT
SMXT
Revenue
$68.6M
$46.6M
Net Profit
$-872.2K
Gross Margin
51.4%
2.7%
Operating Margin
-13.6%
-2.7%
Net Margin
-1.9%
Revenue YoY
3.4%
623.5%
Net Profit YoY
77.7%
EPS (diluted)
$-0.26
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
SMXT
SMXT
Q4 25
$68.6M
$46.6M
Q3 25
$79.1M
$30.6M
Q2 25
$79.2M
$6.9M
Q1 25
$68.5M
$6.9M
Q4 24
$66.3M
$6.4M
Q3 24
$74.9M
$6.3M
Q2 24
$74.4M
Q1 24
$63.1M
Net Profit
INGN
INGN
SMXT
SMXT
Q4 25
$-872.2K
Q3 25
$-5.3M
$-2.3M
Q2 25
$-4.2M
$-1.9M
Q1 25
$-6.2M
$-1.3M
Q4 24
$-3.9M
Q3 24
$-6.0M
$-9.6M
Q2 24
$-5.6M
Q1 24
$-14.6M
Gross Margin
INGN
INGN
SMXT
SMXT
Q4 25
51.4%
2.7%
Q3 25
52.2%
3.1%
Q2 25
52.2%
8.8%
Q1 25
53.1%
20.5%
Q4 24
54.7%
14.5%
Q3 24
55.2%
19.9%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
SMXT
SMXT
Q4 25
-13.6%
-2.7%
Q3 25
-9.0%
-6.9%
Q2 25
-7.7%
-25.7%
Q1 25
-11.2%
-16.7%
Q4 24
-17.2%
-27.9%
Q3 24
-10.4%
-158.4%
Q2 24
-9.5%
Q1 24
-25.8%
Net Margin
INGN
INGN
SMXT
SMXT
Q4 25
-1.9%
Q3 25
-6.7%
-7.4%
Q2 25
-5.2%
-27.6%
Q1 25
-9.0%
-18.7%
Q4 24
-60.6%
Q3 24
-8.0%
-152.0%
Q2 24
-7.5%
Q1 24
-23.1%
EPS (diluted)
INGN
INGN
SMXT
SMXT
Q4 25
$-0.26
$-0.02
Q3 25
$-0.20
$-0.04
Q2 25
$-0.15
$-0.04
Q1 25
$-0.25
$-0.03
Q4 24
$-0.41
$-0.07
Q3 24
$-0.25
$-0.21
Q2 24
$-0.24
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
SMXT
SMXT
Cash + ST InvestmentsLiquidity on hand
$103.7M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$-12.2M
Total Assets
$298.6M
$91.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
SMXT
SMXT
Q4 25
$103.7M
$8.0M
Q3 25
$106.5M
$5.7M
Q2 25
$103.7M
$1.9M
Q1 25
$118.9M
$6.8M
Q4 24
$113.8M
$7.1M
Q3 24
$105.7M
$8.6M
Q2 24
$97.9M
Q1 24
$107.4M
Stockholders' Equity
INGN
INGN
SMXT
SMXT
Q4 25
$192.2M
$-12.2M
Q3 25
$197.2M
$-11.8M
Q2 25
$199.5M
$-15.1M
Q1 25
$198.0M
$-15.9M
Q4 24
$173.9M
$-15.1M
Q3 24
$185.4M
$-10.9M
Q2 24
$187.6M
Q1 24
$191.9M
Total Assets
INGN
INGN
SMXT
SMXT
Q4 25
$298.6M
$91.3M
Q3 25
$307.0M
$58.7M
Q2 25
$312.0M
$38.2M
Q1 25
$308.4M
$38.6M
Q4 24
$296.2M
$38.6M
Q3 24
$306.2M
$43.0M
Q2 24
$308.9M
Q1 24
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
SMXT
SMXT
Operating Cash FlowLast quarter
$-943.0K
$-2.5M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
SMXT
SMXT
Q4 25
$-943.0K
$-2.5M
Q3 25
$2.2M
$3.4M
Q2 25
$4.3M
$220.7K
Q1 25
$-16.8M
$-601.1K
Q4 24
$-3.0M
$-1.3M
Q3 24
$7.0M
$203.6K
Q2 24
$6.7M
Q1 24
$-4.7M
Free Cash Flow
INGN
INGN
SMXT
SMXT
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
INGN
INGN
SMXT
SMXT
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
INGN
INGN
SMXT
SMXT
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
0.0%
Q2 24
0.1%
Q1 24
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

SMXT
SMXT

Yabucoa$35.9M77%
Other$10.7M23%

Related Comparisons